$SAGE News Article - Sage Therapeutics Announces Presentation of Promising Results from the Phase 2 LUMINARY Study of SAGE-718 in Patients with Mild Cognitive Impairment and Mild Dementia due to Alzheimer's Disease https://marketwirenews.com/news-releases/sage...14099.html